Scientists identify source of weight gain from antipsychotics

weight
Credit: Unsplash/CC0 Public Domain

Scientists with UT Southwestern's Peter O'Donnell Jr. Brain Institute have identified the molecular mechanism that can cause weight gain for those using a common antipsychotic medication. The findings, published in the Journal of Experimental Medicine, suggest new ways to counteract the weight gain, including a drug recently approved to treat genetic obesity, according to the study, which involved collaborations with scientists at UT Dallas and the Korea Advanced Institute of Science and Technology.

"If this effect can be shown in , it could give us a way to effectively treat patients for their neuropsychiatric conditions without this serious side effect," says lead author Chen Liu, Ph.D., assistant professor of internal medicine and neuroscience, and with UTSW's O'Donnell Brain Institute and Hypothalamic Research Center.

Up to 20 percent of people who take risperidone, an atypical antipsychotic prescribed for a wide variety of , add more than 7 percent to their baseline weight within a few weeks of treatment, contributing to other health problems such as high blood cholesterol and type 2 diabetes. The weight gain leads many patients to stop using the medication.

In the study, Liu and his colleagues developed a diet for mice that incorporates the drug and identified changes in and neuronal activity within the animals' hypothalamus, a brain region long associated with appetite control. They quickly honed in on a gene called melanocortin 4 (Mc4r), which also is linked to obesity in humans. The Food and Drug Administration recently approved a drug that promotes Mc4r activity to treat some genetic forms of obesity, and Liu and his team showed that giving mice this drug along with risperidone prevented while maintaining effective treatment in models of schizophrenia—offering hope that this strategy might be effective for human patients as well.


Explore further

Team identifies weight-gain receptor linked to antipsychotic drugs

More information: Li Li et al, The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain, Journal of Experimental Medicine (2021). DOI: 10.1084/jem.20202484
Journal information: Journal of Experimental Medicine

Citation: Scientists identify source of weight gain from antipsychotics (2021, May 13) retrieved 16 October 2021 from https://medicalxpress.com/news/2021-05-scientists-source-weight-gain-antipsychotics.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors